مرور روایتی بر نقش سندرم تخمدان پلی‌کیستیک در افزایش خطر نارسایی دهانه رحم در زنان باردار

نوع مقاله : مروری

نویسندگان

1 استادیار گروه مامایی، مرکز تحقیقات مراقبت‌های پرستاری و مامایی، پژوهشکده جامع سلامت مادر و کودک، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید صدوقی، یزد، ایران.

2 دانشجوی دکتری تخصصی بهداشت باروری، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران.

10.22038/ijogi.2025.86910.6389

چکیده

مقدمه: نارسایی دهانه رحم (CI)، یکی از علل مهم سقط جنین و زایمان زودرس و سندرم تخمدان پلی‌کیستیک (PCOS)، یک اختلال اندوکرین مزمن و شایع‌ترین علت ناباروری بدون تخمک‌گذاری است. مطالعه مروری حاضر با هدف تعیین نقش سندرم تخمدان پلی‌کیستیک در افزایش خطر نارسایی دهانه رحم در زنان باردار انجام شد.
روش‌کار: در این مطالعه مروری جهت یافتن مقالات مرتبط، یک جستجوی جامع در بانک­های اطلاعاتی Web of science،SID ، Scopus و PubMed و بدون محدودیت زمانی با کلید واژه­ های انگلیسی Polycystic Ovary Syndrome، Uterine Cervical Incompetence، Incompetent Cervices و کلید واژه ­های فارسی سندرم تخمدان پلی‌کیستیک و نارسایی رحم انجام گرفت. مقالات اصیل پژوهشی با محتوای مرتبط و متن کامل وارد مطالعه شدند. برای ارزیابی مطالعات از چک‌لیست استروب و کانسورت استفاده شد.
یافته ­ها: در مجموع، 13 مقاله واجد شرایط از بین 1276 مقاله یافت شده برای این مطالعه انتخاب شدند. بر اساس نتایج مطالعات، 8 مقاله نشان‌دهنده این بود که شیوع CI طی بارداری در زنان مبتلا به PCOS بالاتر است و افزایش میزان آندروژن­ ها، سطوح بالاتر هورمون ریلکسین خون و استفاده از فن‌آوری­های کمک باروری، از عوامل مرتبط با بالا بودن شیوع CI طی بارداری در زنان مبتلا به PCOS است.
نتیجه ­گیری: بر اساس شواهد، PCOS با افزایش خطر نارسایی دهانه رحم CI در دوران بارداری همراه است. بنابراین، غربالگری و پایش دقیق‌تر دهانه رحم در زنان باردار مبتلا به PCOS توصیه می‌شود تا از عوارض زایمان زودرس و سقط جنین پیشگیری گردد.

کلیدواژه‌ها

موضوعات

عنوان مقاله [English]

A Narrative Review on the Role of Polycystic Ovary Syndrome in the Increasing of Cervical Incompetence in Pregnant Women

نویسندگان [English]

  • Fatemeh ZareMobini 1
  • Fatemehzahra Memar 2
1 Assistant Professor, Department of Midwifery, Research Center for Nursing and Midwifery Care, Comprehensive Research Institute for Maternal and Child Health, School of Nursing and Midwifery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
2 Ph.D candidate in Reproductive Health, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
چکیده [English]

Introduction: Cervical Incompetence (CI), one of the major causes of miscarriage, preterm labor, and Polycystic Ovary Syndrome (PCOS), is a chronic endocrine disorder and the most common cause of anovulatory infertility. The present review study was conducted with aim to determine the role of PCOS in increasing the risk of CI in pregnant women.
Methods: In this review study, to find the related articles, a comprehensive search was conducted in Web of Science, SID, Scopus, and PubMed databases without any time limitation using English keywords of Polycystic Ovary Syndrome, Uterine Cervical Incompetence, Incompetent Cervices, and Persian keywords. Original articles with relevant content and full text were included in the study. The Strobe and Consort checklists were used to evaluate the studies.
Results: In total, 13 eligible articles out of 1276 articles were selected for this study. According to the results of the studies, 8 articles indicate that the prevalence of CI during pregnancy is higher in individuals with PCOS. Elevated androgen levels, higher serum relaxin levels, and the use of assisted reproductive technologies are the associated factors of the higher prevalence of CI during pregnancy in PCOS women.
Conclusion: Based on the evidence, PCOS is associated with an increased risk of CI during pregnancy. Therefore, more precise cervical screening and monitoring is recommended in pregnant women with PCOS to prevent complications such as preterm birth and miscarriage.

کلیدواژه‌ها [English]

  • Cervical Incompetence
  • Miscarriage
  • Pregnancy
  • Preterm Labor
  • Polycystic Ovary Syndrome 

مراجع

  1. Hui SY. Screening for women at risk of spontaneous preterm birth, including cervical incompetence. Best Practice & Research Clinical Obstetrics & Gynaecology 2024; 96:102519.
  2. Gulersen M, Lenchner E, Nicolaides KH, Otsuki K, Rust OA, Althuisius S, et al. Cervical cerclage for short cervix at 24 to 26 weeks of gestation: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. American journal of obstetrics & gynecology MFM 2023; 5(6):100930.
  3. Story L, Shennan A. Cervical cerclage: An evolving evidence base. BJOG: An International Journal of Obstetrics & Gynaecology 2024; 131(12):1579-86.
  4. Gupta S, Einarsson JI. Laparoscopic abdominal cerclage. Obstetrics and Gynecology Clinics 2022; 49(2):287-97.
  5. Wang Y, Gu X, Tao L, Zhao Y. Co-morbidity of cervical incompetence with polycystic ovarian syndrome (PCOS) negatively impacts prognosis: A retrospective analysis of 178 patients. BMC pregnancy and Childbirth 2016; 16(1):308.
  6. Han Y, Li M, Ma H, Yang H. Cervical insufficiency: a noteworthy disease with controversies. Journal of perinatal medicine 2020; 48(7):648-55.
  7. Wu Y, Cai M, Liang X, Yang X. The prevalence of cervical insufficiency in Chinese women with polycystic ovary syndrome undergone ART treatment accompanied with negative prognosis: a retrospective study. Journal of Obstetrics and Gynaecology 2021; 41(6):888-92.
  8. Thakur M, Jenkins SM, Mahajan K. Cervical insufficiency. InStatPearls [Internet] 2024 Oct 6. StatPearls Publishing.
  9. Goodarzi F, Mojahed S, ZareMobini F, Sarebanhassanabadi M. Effect of Using 5A’s Model for Self-management Counseling on Quality of Life and Self-Efficacy in Women with Polycystic Ovary Syndrome: A Randomized Clinical Trial. Iranian Journal of Nursing and Midwifery Research 2025; 30(6):832-8.
  10. ZareMobini F, Kazemi A, Farajzadegan Z. A comprehensive mental health care program for women with polycystic ovary syndrome: protocol for a mixed methods study. Reproductive health 2018; 15(1):46.
  11. Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, et al. Polycystic ovary syndrome. Nature Reviews Disease Primers 2024; 10(1):27.
  12. ZareMobini F, Farajzadegan Z, Kazemi A, Salehi M. Effect of using 5A’s model for lifestyle counseling on psychological symptoms in women with polycystic ovary syndrome: a randomized field trial. Scientific Reports 2022; 12(1):21847.
  13. Morshedi T, Salehi M, Farzad V, Hassani F, Shakibazadeh E. The status of relationship between coping strategies and quality of life in women with polycystic ovary syndrome. Journal of education and health promotion 2021; 10(1).
  14. Costello MF, Misso ML, Balen A, Boyle J, Devoto L, Garad RM, et al. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Human reproduction open 2019; 2019(1):hoy021.
  15. Bellver J, Rodríguez-Tabernero L, Robles A, Muñoz E, Martínez F, Landeras J, et al. Polycystic ovary syndrome throughout a woman’s life. Journal of assisted reproduction and genetics 2018; 35(1):25-39.
  16. Louwers YV, Laven JS. Characteristics of polycystic ovary syndrome throughout life. Therapeutic Advances in Reproductive Health 2020; 14:2633494120911038.
  17. Stańczak NA, Grywalska E, Dudzińska E. The latest reports and treatment methods on polycystic ovary syndrome. Annals of medicine 2024; 56(1):2357737.
  18. Sedghi S, Almassi Nokiani F, Fakehi M, Tahermanesh K, Akbari P. The effect of vitamin D administration on biochemical factors in polycystic ovary syndrome patients: a randomized controlled clinical trial study. The Iranian Journal of Obstetrics, Gynecology and Infertility 2024; 26(11):34-43.
  19. Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nature Reviews Endocrinology 2025; 21(4):230-44.
  20. Mansour A, Mirahmad M, Mohajeri-Tehrani MR, Jamalizadeh M, Hosseinimousa S, Rashidi F, et al. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population. Scientific reports 2023; 13(1):10269.
  21. Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends in cardiovascular medicine 2020; 30(7):399-404.
  22. Yu T, Wu D, Cao Y, Zhai J. Association between menstrual patterns and adverse pregnancy outcomes in patients with polycystic ovary syndrome. Frontiers in Endocrinology 2021; 12:740377.
  23. Mahmood AR, Abdullah MR, Khalaf HS, Ahmed WA. Reproductive Dysfunction in Women with PCOS: A Review Article. Ibn AL-Haitham Journal For Pure and Applied Sciences 2024; 37(2):231-41.
  24. Pal S, Mahapatra M. Impact of Polycystic Ovary Syndrome (PCOS) on Mental Well-Being and Self-Esteem among Women in India. International Journal of Indian Psychȯlogy 2024; 12(2).
  25. Manchanda S, Bhatt S. Comparing Anxiety, Depression, Stress, Eating Behaviour, and Health Promotion in PCOS and Non-PCOS Individuals. International Journal of Interdisciplinary Approaches in Psychology 2024; 2(4):1498-521.
  26. Lin W, Wang Y, Zheng L. Polycystic ovarian syndrome (PCOS) and recurrent spontaneous abortion (RSA) are associated with the PI3K-AKT pathway activation. PeerJ 2024; 12:e17950.
  27. Aboulghar M, Aboulghar M. The dilemma of polycystic ovary syndrome and pregnancy complications. Fertility and Sterility 2024; 122(6):1014-5.
  28. Valdimarsdottir R, Vanky E, Elenis E, Ahlsson F, Lindström L, Junus K, et al. Polycystic ovary syndrome and gestational diabetes mellitus association to pregnancy outcomes: A national register‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica 2025; 104(1):119-29.
  29. Guo X, Yao Y, Wang T, Wu J, Jiang R. The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis. Hypertension in pregnancy 2024; 43(1):2379389.
  30. McDonnell R, Hart RJ. Pregnancy-related outcomes for women with polycystic ovary syndrome. Women's Health 2017; 13(3):89-97.
  31. Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, et al. Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Frontiers in endocrinology 2021; 12:741764.
  32. Cheng T, Shi H, Bu Z, Yu Y, Song W, Haixia J, et al. Contribution of cervical incompetence to occurrence of second trimester abortion in patients with polycystic ovary syndrome during the frozen embryo transfer cycle. Frontiers in Endocrinology 2024; 15:1411618.
  33. Han Y, Wang N, Wang C, Yang H. Analysis of risk factors for cervical insufficiency: a retrospective controlled study. Authorea Preprints; 2024.
  34. Feigenbaum SL, Crites Y, Hararah MK, Yamamoto MP, Yang J, Lo JC. Prevalence of cervical insufficiency in polycystic ovarian syndrome. Human Reproduction 2012; 27(9):2837-42.
  35. Fede C, Sun Y, Zhao X, Angelini A, Ruggieri P, Stecco C. Effect of Androgens on Human Fascia. Biology 2025; 14(7):746.
  36. Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. Bmj 2005; 331(7524):1064-5.
  37. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. International journal of surgery 2014; 12(12):1495-9.
  38. Shakeri M, Taghipour A, Mazinani MS, Emamverdi Z, Hadianfar A, Yousefi R. Assessment of Randomized Clinical Trials articles in Medical Journal of Mashhad University of Medical Sciences based on CONSORT statement. Medical Journal of Mashhad university of Medical Sciences 2021; 64(3):3155-66.
  39. Cheng T, Shi H, Bu Z, Yu Y, Song W, Jin H, et al. Effect of cervical incompetence in patients with polycystic ovary syndrome enduring second-trimester abortion during the frozen-embryo transfer cycle: A retrospective study; 2023.
  40. Yamamoto M, Feigenbaum SL, Crites Y, Escobar GJ, Yang J, Ferrara A, et al. Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome. Journal of perinatology 2012; 32(10):770-6.
  41. Liu Q, Wang J, Xu Q, Kong L, Wang J. A retrospective cohort study of obstetric complications and birth outcomes in women with polycystic ovarian syndrome: obstetric complications and birth outcomes in women with PCOS. Journal of Obstetrics and Gynaecology 2022; 42(4):574-9.
  42. Zhao X, Ye S, Yan X, Li R, Wang Y. Risk factors for cervical insufficiency in women with polycystic ovarian syndrome: a cohort study; 2022.
  43. Shetelig Løvvik T, Stridsklev S, Carlsen SM, Salvesen Ø, Vanky E. Cervical length and androgens in pregnant women with polycystic ovary syndrome: has metformin any effect?. The Journal of Clinical Endocrinology & Metabolism 2016; 101(6):2325-31.
  44. Gu X, Wang D, Tao L, Jin H, Zhao Y, Wang Y. Serum relaxin in cervical incompetence patients. Zhonghua yi xue za zhi 2015; 95(35):2817-20.
  45. Xinhua Z, Baozhi G, Huanhuan G. Analysis of risk factors of cervical insufficiency in patients with polycystic ovary syndrome and late abortion undergoing pregnancy-assisted therapy. International Medicine and Health Guidance News 2022; 28(8):1077.
  46. Petrichenko YG, Koloda YA, Korennaya VV, Podzolkova NM. Hysteroscopic cervical cerclage before embryo transfer for the prevention of preterm birth in polycystic ovary syndrome patient. Consilium Medicum 2019; 21(6):38-41.
مجله زنان، مامایی و نازایی ایران
دوره 28، شماره 10
دی 1404
صفحه 77-88

فایل ها

هم رسانی

ارجاع به این مقاله

آمار